Abstract:Strategies concerning thyroid anomalies in patients confirmed with psoriasis, either on clinical level or molecular levels, and their genetic findings remain an open issue. Identification of the exact subgroup of individuals that are candidates to endocrine assessments is also controversial. Our purpose in this work was to overview clinical and pathogenic data concerning psoriasis and thyroid comorbidities from a dual perspective (dermatologic and endocrine). This was a narrative review of English literature between January 2016 and January 2023. We included clinically relevant, original articles with different levels of statistical evidence published on PubMed. We followed four clusters of conditions: thyroid dysfunction, autoimmunity, thyroid cancer, and subacute thyroiditis. A new piece of information in this field was the fact that psoriasis and autoimmune thyroid diseases (ATD) have been shown to be related to the immune-based side effects of modern anticancer drugs-namely, immune checkpoint inhibitors (ICP). Overall, we identified 16 confirmatory studies, but with heterogeneous data. Psoriatic arthritis had a higher risk of positive antithyroperoxidase antibodies (TPOAb) (25%) compared to cutaneous psoriasis or control. There was an increased risk of thyroid dysfunction versus control, and hypothyroidism was the most frequent type of dysfunction (subclinical rather than clinical), among thyroid anomalies correlated with >2-year disease duration, peripheral > axial and polyarticular involvement. With a few exceptions, there was a female predominance. Hormonal imbalance included, most frequently, low thyroxine (T4) and/or triiodothyronine (T3) with normal thyroid stimulating hormone (TSH), followed by high TSH (only one study had higher total T3). The highest ratio of thyroid involvement concerning dermatologic subtypes was 59% for erythrodermic psoriasis. Most studies found no correlation between thyroid anomalies and psoriasis severity. Statistically significant odds ratios were as follows: hypothyroidism: 1.34-1.38; hyperthyroidism: 1.17-1.32 (fewer studies than hypo); ATD: 1.42-2.05; Hashimoto's thyroiditis (HT): 1.47-2.09; Graves' disease: 1.26-1.38 (fewer studies than HT). A total of 8 studies had inconsistent or no correlations, while the lowest rate of thyroid involvement was 8% (uncontrolled studies). Other data included 3 studies on patients with ATD looking for psoriasis, as well as 1 study on psoriasis and thyroid cancer. ICP was shown to potentially exacerbate prior ATD and psoriasis or to induce them both de novo (5 studies). At the case report level, data showed subacute thyroiditis due to biological medication (ustekinumab, adalimumab, infliximab). Thyroid involvement in patients with psoriasis thus remained puzzling. We observed significant data that confirmed a higher risk of identifying positive antibodies and/or thyroid dysfunction, especially hypothyroidism, in these subjects. Awareness will be necessary to improve overall outcomes. The exact profile of individuals diagnosed with psoriasis who should be screened by the endocrinology team is still a matter of debate, in terms of dermatological subtype, disease duration, activity, and other synchronous (especially autoimmune) conditions.

Immune-Molecular Link between Thyroid and Skin Autoimmune Diseases: A Narrative Review

Conundrum for Psoriasis and Thyroid Involvement

Skin Immunity and Its Dysregulation in Atopic Dermatitis, Hidradenitis Suppurativa and Vitiligo.

Vitiligo and Hashimoto's thyroiditis: Autoimmune diseases linked by clinical presentation, biochemical commonality, and autoimmune/oxidative stress-mediated toxicity pathogenesis.

The Role of VD/VDR Signaling Pathway in Autoimmune Skin Diseases

Is Atopic Dermatitis a Risk Factor for Thyroid Autoimmunity? - A Cross-Sectional Study from a Tertiary Care Center in India

Epigenetic Dysregulation in Autoimmune and Inflammatory Skin Diseases

Autoimmune thyroid disorders and rheumatoid arthritis: A bidirectional interplay

Allergy and autoimmunity in children: non-mutually exclusive diseases. A narrative review

Prevalence of Autoimmune Thyroid Disease in Patients with Psoriasis: a Meta-Analysis

The attentive focus on T cell‐mediated autoimmune pathogenesis of psoriasis, lichen planus and vitiligo

Vitamin D and Autoimmune Thyroid Disease—Cause, Consequence, or a Vicious Cycle?

The causal effects of inflammatory and autoimmune skin diseases on thyroid diseases: evidence from Mendelian randomization study

Differential impact of environmental factors on systemic and localized autoimmunity

Clinical Analysis and Immunological Characteristics of Patients with Dermatomyositis and Thyroid Dysfunction

The relationship between the gut microbiota and thyroid disorders

Association between alopecia areata and thyroid dysfunction

The human microbiome in immunobullous disorders and lichen planus

Adaptive and Innate Immunity in Psoriasis and Other Inflammatory Disorders

The Interplay Between Keratinocytes and Immune Cells in the Pathogenesis of Psoriasis

Type-2 immunity associated with type-1 related skin inflammatory diseases: friend or foe?